HK1025901A1 - Method of enhancing bioavailability of fexofenadine and its derivatives - Google Patents

Method of enhancing bioavailability of fexofenadine and its derivatives

Info

Publication number
HK1025901A1
HK1025901A1 HK00105070A HK00105070A HK1025901A1 HK 1025901 A1 HK1025901 A1 HK 1025901A1 HK 00105070 A HK00105070 A HK 00105070A HK 00105070 A HK00105070 A HK 00105070A HK 1025901 A1 HK1025901 A1 HK 1025901A1
Authority
HK
Hong Kong
Prior art keywords
fexofenadine
derivatives
enhancing bioavailability
bioavailability
enhancing
Prior art date
Application number
HK00105070A
Other languages
English (en)
Inventor
Kin-Kai Hwang
Dennis H Giesing
Gail H Hurst
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of HK1025901A1 publication Critical patent/HK1025901A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A61K31/75—Polymers of hydrocarbons of ethene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
HK00105070A 1997-08-14 2000-08-15 Method of enhancing bioavailability of fexofenadine and its derivatives HK1025901A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91156397A 1997-08-14 1997-08-14
PCT/US1998/015098 WO1999008690A1 (en) 1997-08-14 1998-07-21 Method of enhancing bioavailability of fexofenadine and its derivatives

Publications (1)

Publication Number Publication Date
HK1025901A1 true HK1025901A1 (en) 2000-12-01

Family

ID=25430473

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00105070A HK1025901A1 (en) 1997-08-14 2000-08-15 Method of enhancing bioavailability of fexofenadine and its derivatives

Country Status (30)

Country Link
EP (1) EP1003528B1 (uk)
JP (1) JP4295913B2 (uk)
KR (1) KR100522985B1 (uk)
CN (1) CN1143680C (uk)
AR (1) AR018505A1 (uk)
AT (1) ATE224721T1 (uk)
AU (1) AU725965C (uk)
BR (1) BR9811937A (uk)
CA (1) CA2301267C (uk)
CZ (1) CZ293666B6 (uk)
DE (1) DE69808303T2 (uk)
DK (1) DK1003528T3 (uk)
EE (1) EE04263B1 (uk)
ES (1) ES2179523T3 (uk)
HK (1) HK1025901A1 (uk)
HU (1) HU226823B1 (uk)
ID (1) ID24463A (uk)
IL (1) IL134521A (uk)
NO (1) NO325148B1 (uk)
NZ (1) NZ502133A (uk)
OA (1) OA11287A (uk)
PL (1) PL191607B1 (uk)
PT (1) PT1003528E (uk)
RU (1) RU2197967C2 (uk)
SK (1) SK283868B6 (uk)
TR (1) TR200000419T2 (uk)
TW (1) TWI240633B (uk)
UA (1) UA64765C2 (uk)
WO (1) WO1999008690A1 (uk)
ZA (1) ZA987221B (uk)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU701042B2 (en) 1995-02-28 1999-01-21 Aventisub Llc Pharmaceutical composition for piperidinoalkanol compounds
EE04294B1 (et) * 1997-08-26 2004-06-15 Hoechst Marion Roussel, Inc. Farmatseutiline kompositsioon piperidinoalkanooldekongestandi kombineerimiseks
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
WO2003101437A2 (en) * 2002-05-29 2003-12-11 Aventis Pharmaceuticals Holdings Inc. Method of treating asthma using fexofenadine
JP2008120684A (ja) * 2005-03-07 2008-05-29 Kumamoto Univ 抗アレルギー薬
KR101106374B1 (ko) 2009-06-05 2012-01-19 민병욱 고체연료에 의한 가연성 가스 발생 장치
KR101117014B1 (ko) * 2009-09-09 2012-06-14 민병욱 부패성 폐기물의 바이오매스 처리에 의한 폐자원 재활용 방법 및 장치
CN101843616B (zh) * 2010-06-04 2011-07-27 西安万隆制药有限责任公司 一种盐酸非索非那定与微晶纤维素组合物及其制备方法
RU2453315C2 (ru) * 2010-08-17 2012-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения аллергических заболеваний
MX2013013575A (es) 2011-05-20 2014-09-15 Aventis Pharma Inc Composicion farmaceutica que comprende fenofenadina.
RU2504018C1 (ru) * 2012-05-28 2014-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации Способ моделирования состояния индукции функциональной активности гликопротеина-р финастеридом в эксперименте
RU2553362C1 (ru) * 2014-01-09 2015-06-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ моделирования состояния ингибирования функциональной активности гликопротеина-р линестренолом в эксперименте
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
WO1996040792A1 (en) * 1995-06-07 1996-12-19 Novo Nordisk A/S Modification of polypeptides
JPH11507356A (ja) * 1995-06-07 1999-06-29 アブマックス，インコーポレイティド 経口薬理化合物の生物有用性を高めるためのエッセンシャルオイルの利用

Also Published As

Publication number Publication date
KR100522985B1 (ko) 2005-10-21
PL191607B1 (pl) 2006-06-30
AU8505098A (en) 1999-03-08
UA64765C2 (uk) 2004-03-15
EE200000069A (et) 2000-10-16
ES2179523T3 (es) 2003-01-16
ATE224721T1 (de) 2002-10-15
RU2197967C2 (ru) 2003-02-10
NZ502133A (en) 2002-03-28
AR018505A1 (es) 2001-11-28
DK1003528T3 (da) 2003-02-03
PT1003528E (pt) 2003-02-28
CN1143680C (zh) 2004-03-31
DE69808303D1 (de) 2002-10-31
EP1003528A1 (en) 2000-05-31
BR9811937A (pt) 2000-09-05
CA2301267A1 (en) 1999-02-25
KR20010022845A (ko) 2001-03-26
NO20000706L (no) 2000-04-13
SK1842000A3 (en) 2000-08-14
HU226823B1 (hu) 2009-11-30
JP4295913B2 (ja) 2009-07-15
EE04263B1 (et) 2004-04-15
JP2001515041A (ja) 2001-09-18
SK283868B6 (sk) 2004-03-02
CN1267221A (zh) 2000-09-20
AU725965B2 (en) 2000-10-26
WO1999008690A1 (en) 1999-02-25
EP1003528B1 (en) 2002-09-25
CA2301267C (en) 2004-07-13
NO325148B1 (no) 2008-02-11
HUP0003189A3 (en) 2001-04-28
DE69808303T2 (de) 2003-05-22
CZ293666B6 (cs) 2004-06-16
NO20000706D0 (no) 2000-02-11
IL134521A0 (en) 2001-04-30
ID24463A (id) 2000-07-20
HUP0003189A2 (en) 2001-03-28
CZ2000522A3 (cs) 2000-09-13
TR200000419T2 (tr) 2000-09-21
PL338579A1 (en) 2000-11-06
OA11287A (en) 2003-10-22
AU725965C (en) 2004-04-22
TWI240633B (en) 2005-10-01
ZA987221B (en) 1999-02-15
IL134521A (en) 2005-07-25

Similar Documents

Publication Publication Date Title
PL339551A1 (en) Derivatives of rezorcin
PL339660A1 (en) Derivatives of amidocarboxylic acids
PL339452A1 (en) Method of and intermediate products for obtaining antifilanes
PL340461A1 (en) Derivatives of isothiazocarboxylic acid
IL134521A0 (en) Method of enhancing bioavailability of fexofenadine and its derivatives
PL329808A1 (en) Derivatives of indolylpyrrolyden methylpyrrole and method of obtaining them
PL335163A1 (en) Method of obtaining substituted thiazolydinodione
HUP0002623A3 (en) Dielectrokinetic sensor and method of its application
PL335074A1 (en) Method of obtaining eprosartane
PL335075A1 (en) Method of obtaining eprosartane
PL334769A1 (en) Derivatives of 5-aroylnaphtene
PL337690A1 (en) Method of obtaining 4-substituted 1h-indolo-3-glyoxamides
PL334901A1 (en) Method of obtaining benzothiazolones
PL339188A1 (en) Method of obtaining oxaphosphorin-2-amines
PL341358A1 (en) Method of obtaining paroxetin chlorhydride
ZA985064B (en) Derivatives of pentaerythrits
PL338777A1 (en) Derivative of piperidinylmethyloxazolydinone
SI1003528T1 (en) Method of enhancing bioavailability of fexofenadine and its derivatives
PL340915A1 (en) Method of obtaining azacycloalkylalkanoyl pseudotetrapeptides
PL335373A1 (en) Method of obtaining derivatives of 4h-4-oxoquinolysine-3-carboxylic acid
PL339304A1 (en) Method of obtaining derivatives of 1-phenylparazolin-3-carboxylic acid
PL341302A1 (en) Method of obtaining chlorobenzoxazoles
PL336266A1 (en) Method of obtaining epsilon-caprolactams
PL335887A1 (en) Method of obtaining arylaminotriazole pyridines
PL322543A1 (en) Method of obtaining dexphenyl fluramine hydrochloride

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20180720